CLGN · CollPlant Biotechnologies Ltd
$0.28
-0.02 (-7.67%)
At close · Aug 27
Market Cap
$5.65M
Shares
18.91M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.31
Open$0.30
Day$0.29–0.32
52W close$0.27–3.14
Avg vol 30d58K
Short int22K · 0.1% float · 1.0d
Short vol15%
Last earningsSep 30, 2024
DataJan 2020–Aug 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 15.2 · calm
Equity put/call 0.64
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−63%
below
Price vs 50-day avg
−7%
below
RSI (14)
47
neutral
MACD trend
Negative
52-week position
1%
near low
Momentum
relative strength
1-month return
−1%
trailing
6-month return
−52%
trailing
YTD return
−78%
this year
Relative strength
−64%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-25% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.12% of float · ▲ +45.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
15 holders — mid 3-yr range
Squeeze score
34
low risk · 0–100
Fundamentals
Revenue growth
+360%
Y/Y
Gross margin
65%
expanding
EPS growth
+35%
Y/Y
Free cash flow
$-9.4M
Balance sheet
$5.2M
net cash
Quant / Vol
risk profile
Volatility
108%
annualized · 1-yr
Max drawdown
−91%
past year
ATR
11.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−63%
Bearish
Price vs 50-day avg
−7%
Bearish
RSI (14)
47
Neutral
MACD trend
Negative
Bearish
52-week position
1%
Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-25% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.12% of float · ▲ +45.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
15 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 1%
Range high $3
vs 200-day avg -63%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CLGN
this stock
CollPlant Biotechnologies Ltd
|
$5.65M | -78.0% | +360.4% | — | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.72B | +20.7% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$83.89B | +5.6% | +20.8% | 20.2 | 2.3% |
|
ARGX
Argenx SE
|
$65.12B | +24.5% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.92B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
15
- % held
- 8.8%
- Net QoQ
- +142.3K sh
- Top holder
- PINNACLE ASSOCIATES LTD
Held
Float
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CLGN | -4.5% | -1.4% | -51.6% | +12.6% | -78.0% |
| SPY | -0.4% | +5.0% | +12.4% | +2.6% | +12.3% |
| vs SPY | -4.1% | -6.5% | -64.0% | +10.1% | -90.4% |
Key facts
CIK
1631487
CUSIP
M2R51X116
13F (30d)
13 filings
13 filers
Visit website
Investor relations